Most chemotherapy regimens employed in the chronic hematologic setting were included in this retrospective analysis in order to identify, in the absence of G-CSF administration, the incidence and the duration of grade 4 neutropenia, FN, and the median onset of nadir. The gene discussed is CSF3; the disease is Decreased total neutrophil count.